search
Back to results

The Value of HBA in the Evaluation of Idiopathic Infertility

Primary Purpose

Infertility

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
HBA binding assay
Sponsored by
St. Luke's-Roosevelt Hospital Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Infertility

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • . All groups will include females under 40 years of age undergoing 1st IVF cycle 3 groups

    1. Abnormal Semen Analysis (sperm count <10 million/ml and /or rapid progressive motility < 50 %, WHO morphology <30%) normal HSG , normal ovarian reserve testing and ovulation testing
    2. Unexplained infertility- normal ovarian reserve testing and ovulation testing (FSH< 10, AMH>1.0) Normal ovulatory cycles, normal WHO semen analysis. Normal tubes on HSG or Laparoscopy
    3. Tubal infertility as assessed by HSG or laparoscopy

Exclusion Criteria:

  • women over 40, prior failed IVF

Sites / Locations

  • The Continuum Reproductive Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

hylauronin binding assay

Arm Description

HBA binding assay will be preformed on the discarded portion of semen analysis used for IVF.

Outcomes

Primary Outcome Measures

In each of these groups we will assess presence of HBA bound sperm

Secondary Outcome Measures

Full Information

First Posted
September 7, 2012
Last Updated
August 31, 2015
Sponsor
St. Luke's-Roosevelt Hospital Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01683435
Brief Title
The Value of HBA in the Evaluation of Idiopathic Infertility
Official Title
The Value of Hyaluronic Binding Assays (HBA) in the Evaluation of Idiopathic Infertility
Study Type
Interventional

2. Study Status

Record Verification Date
August 2015
Overall Recruitment Status
Completed
Study Start Date
November 2011 (undefined)
Primary Completion Date
January 2012 (Actual)
Study Completion Date
January 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
St. Luke's-Roosevelt Hospital Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
We would like to determine if HBA® testing of sperm in couples with presumed idiopathic infertility will reveal lower binding percentages than in couples with an identifiable cause of infertility either male factor or tubal factor
Detailed Description
We would like to determine if HBA® testing of sperm in couples with presumed idiopathic infertility will reveal lower binding percentages than in couples with an identifiable cause of infertility either male factor or tubal factor We would like to determine if patients with abnormal HBA binding have decreased IVF outcome: decreases clinical pregnancy rate, implantation rate, and increased miscarriage rate

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Actual)

8. Arms, Groups, and Interventions

Arm Title
hylauronin binding assay
Arm Type
Experimental
Arm Description
HBA binding assay will be preformed on the discarded portion of semen analysis used for IVF.
Intervention Type
Other
Intervention Name(s)
HBA binding assay
Intervention Description
HBA binding assay will be preformed on the discarded portion of semen analysis used for IVF.
Primary Outcome Measure Information:
Title
In each of these groups we will assess presence of HBA bound sperm
Time Frame
immediate at time of preforming HBA test

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: . All groups will include females under 40 years of age undergoing 1st IVF cycle 3 groups Abnormal Semen Analysis (sperm count <10 million/ml and /or rapid progressive motility < 50 %, WHO morphology <30%) normal HSG , normal ovarian reserve testing and ovulation testing Unexplained infertility- normal ovarian reserve testing and ovulation testing (FSH< 10, AMH>1.0) Normal ovulatory cycles, normal WHO semen analysis. Normal tubes on HSG or Laparoscopy Tubal infertility as assessed by HSG or laparoscopy Exclusion Criteria: women over 40, prior failed IVF
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin Keltz, MD
Organizational Affiliation
Mount Sinai St. Luke's
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Continuum Reproductive Center
City
New York
State/Province
New York
ZIP/Postal Code
10019
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Value of HBA in the Evaluation of Idiopathic Infertility

We'll reach out to this number within 24 hrs